Literature DB >> 1322015

Clinical measures to promote corneal epithelial healing.

R R Pfister1.   

Abstract

It is necessary to know the specific pathobiology of a persistent epithelial defect to determine the strategy to be employed to assist in its repair. Lid position and function must be normal and any deficiency in the quantity and quality of the tears enhanced by tear preparations and closure of the lacrimal canaliculi. Adverse drug effects must be eliminated. Multiple corneal punctures and excision of reduplicated basal lamina have virtually eliminated the problem of recurrent corneal erosions. Control of any inflammatory process also speeds healing. Vitamin supplements, especially A, reverse defects associated with xerophthalmia. In any of these diseases, mechanical treatments consisting of soft contact lenses for persistent epithelial defects and collagen shields for the delivery of antibiotics or steroids to the eye may be employed. Tarsorrhaphy relieves the problem of persistent epithelial defects in neurotrophic keratitis and a variety of other conditions characterized by persistent surface breakdown. Preliminary data from open label studies of epidermal growth factors and fibronectin are encouraging but not yet conclusive.

Entities:  

Mesh:

Year:  1992        PMID: 1322015     DOI: 10.1111/j.1755-3768.1992.tb02172.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Suppl


  10 in total

1.  Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects.

Authors:  R B Vajpayee; N Mukerji; R Tandon; N Sharma; R M Pandey; N R Biswas; N Malhotra; S A Melki
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Role of multilayered amniotic membrane transplantation for the treatment of resistant corneal ulcers in North India.

Authors:  Shalini Mohan; Ina Budhiraja; Amit Saxena; Perwez Khan; S K Sachan
Journal:  Int Ophthalmol       Date:  2013-07-27       Impact factor: 2.031

Review 3.  The role of fibronectin in corneal wound healing explored by a physician-scientist.

Authors:  Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2012-07-27       Impact factor: 2.447

4.  Corneal densitometry after photorefractive keratectomy, laser-assisted in situ keratomileusis, and small-incision lenticule extraction.

Authors:  F Poyales; N Garzón; J Mendicute; I Illarramendi; P Caro; O Jáñez; F Argüeso; A López
Journal:  Eye (Lond)       Date:  2017-06-16       Impact factor: 3.775

5.  Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects.

Authors:  Elif Erdem; Meltem Yagmur; Inan Harbiyeli; Hande Taylan-Sekeroglu; Reha Ersoz
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

6.  Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation.

Authors:  P Prabhasawat; N Tesavibul; W Komolsuradej
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

7.  Galectin-3 enhances extracellular matrix associations and wound healing in monkey corneal epithelium.

Authors:  Atsuko Fujii; Thomas R Shearer; Mitsuyoshi Azuma
Journal:  Exp Eye Res       Date:  2015-06-10       Impact factor: 3.467

Review 8.  Use of Acellular Umbilical Cord-Derived Tissues in Corneal and Ocular Surface Diseases.

Authors:  Arianna A Tovar; Ian A White; Alfonso L Sabater
Journal:  Medicines (Basel)       Date:  2021-02-09

9.  Cataracts in diabetic patients: a review article.

Authors:  Mohammad-Ali Javadi; Siamak Zarei-Ghanavati
Journal:  J Ophthalmic Vis Res       Date:  2008-01

Review 10.  Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis.

Authors:  Maria Rosaria De Pascale; Michele Lanza; Linda Sommese; Claudio Napoli
Journal:  J Ophthalmol       Date:  2015-10-04       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.